Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to ...
A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD ...
A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in ...
Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 ...
Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...
HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon ...
Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at home—for a steep price. Full-face LED masks like this one can cost up to several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback